Latest Breaking News On - Borisr minev - Page 1 : comparemela.com

Calidi Biotherapeutics Announces Presentation of Clinical Study for NeuroNova with Recurrent High Grade Glioma at the 8th Oncolytic Virotherapy Summit

Company to also share progress with cell-based virotherapy platforms for advanced solid tumors .

United statesSan diegoCalidi biotherapeuticsAntoniof santidrian pharmBorisr minevAntoniof santidrianJana portnowCalidi neuronovaOncolytic virotherapyOncolytic virotherapiesScientific affairsNorthwestern universityScientific affairs of calidi biotherapeuticsCalidi biotherapeutics incDepartment of medical oncology therapeutics researchCity of hope comprehensive cancer center presentation

Calidi Biotherapeutics (NYSEAM: CLDI) Presents Data on CLD-201 Demonstrating Inhibition of Tumor Growth and Induction of Robust Anti-Tumor Immunity at the Society for Immunotherapy of Cancer s 38th Annual Meeting (SITC 2023) -November 03, 2023 at 07:02 am EDT

Poster also details clinical readiness for CLDI-201 and plans to initiate Phase 1 study in 2024 .

San diegoUnited statesAntoniof santidrianCalidi biotherapeuticsBorisr minevOncolytic virotherapiesSociety for immunotherapy of cancerScientific affairsCalidi biotherapeutics incChief scientific officerNovel stem cell based platformScientific publicationsNote regarding forward looking

Calidi Biotherapeutics (CLDI) (CLDI) Presents Data on CLD-201 Demonstrating Inhibition of Tumor Growth and Induction of Robust Anti-Tumor Immunity

Calidi Biotherapeutics (CLDI) (CLDI) Presents Data on CLD-201 Demonstrating Inhibition of Tumor Growth and Induction of Robust Anti-Tumor Immunity
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesCalidi biotherapeuticsBorisr minevOncolytic virotherapiesAntoniof santidrianScientific affairsCalidi biotherapeutics incSociety for immunotherapy of cancerChief scientific officerNovel stem cell based platformScientific publications

Calidi Biotherapeutics To Present New Preclinical Data Highlighting Cell-based Virotherapy (SuperNova) Platform Technology at SITC 2023

Calidi Biotherapeutics, Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced a poster highlighting new preclinical data and clinical.

United statesSan diegoBorisr minevAntoniof santidrianCalidi biotherapeuticsOncolytic virotherapiesCalidi biotherapeutics incSociety for immunotherapy of cancerScientific affairsAnnual meetingNovel stem cell based platformChief scientific officerNote regarding forward looking

Form 425 First Light Acquisition Filed by: First Light Acquisition Group, Inc

Form 425 First Light Acquisition Filed by: First Light Acquisition Group, Inc
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesOrange countySan diegoJana portnowBorisr minevStephen thesingKaren aboodyLetisia marquezCalidi biotherapeuticsLos angelesStephen jasperCalifornia institute for regenerative medicineCalidi biotherapeutics incNational cancerCommission fileSecurities exchange